OPTIMIZATION of ADVANCED MR SEQUENCES
- Conditions
- MRIMental DisordersBrain TumorNeurosciencesStroke
- Registration Number
- NCT05618990
- Lead Sponsor
- Centre Hospitalier St Anne
- Brief Summary
This monocentric methodological study aims at optimizing advanced MR sequences for image quality (reduced artefacts, signal to noise ratio, acquisition time, stability of quantitative measurements) on a new MR unit dedicated to research in clinical and cognitive neuroscience.
- Detailed Description
Primary goal : Optimization of MR protocols and validation of acquisition parameters of advanced MR sequences on healthy volunteers or patients on a new 3T MR unit dedicated to research in neurosciences.
Secondary goals
1. Perform acquisitions to validate the feasibility of research MR protocols (pilot subjects)
2. reproducibility studies
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 300
- 18 ans
- Covered by social security
- For women in age of procreation, under efficient contraception
- Written consent
- Any MR contraindication
- Claustrophobia
- Pregnancy
- Under judiciary protection
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method MR sequences optimization 72 months Optimization of MR protocols and validation of acquisition parameters of advanced MR sequences on healthy volunteers or patients on a new 3T MR unit dedicated to research in neurosciences. Outcome measures depend on each pulse optimized sequence (signal-to-noise ratio, contrast-to-noise ratio, quantitative MR biomarkers).
- Secondary Outcome Measures
Name Time Method Reproducibility studies 72 months Reproducibility studies (quantitative parameters, effect of denoising ...). Outcome measures depend on each pulse optimized sequence (artifacts, signal-to-noise ratio, contrast-to-noise ratio, quantitative MR biomarkers).
Pilot studies 72 months Feasibility studies in cognitive neurosciences. Outcome measures depend on each MR protocol (artifacts, signal-to-noise ratio, contrast-to-noise ratio, quantitative MR biomarkers).
Trial Locations
- Locations (1)
OPPENHEIM Catherine
🇫🇷Paris, France